Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „cabozantinib“
Suchtreffer
Begriffe & Kennungen
Opdivo · 4.8 · 30 Combination with Combination with Combination with ipilimumab (with or chemotherapy cabozantinib without ch
Eintrag öffnenOpdivo · 4.8 · 31 Combination with Combination with Combination with ipilimumab (with or chemotherapy cabozantinib without ch
Eintrag öffnenOpdivo · 4.8 · 32 Combination with Combination with Combination with ipilimumab (with or chemotherapy cabozantinib without ch
Eintrag öffnenOpdivo · 4.8 · Elevated liver enzymes when nivolumab is combined with cabozantinib in RCC In a clinical study of previously u
Eintrag öffnenOpdivo · 4.8 · Elevated liver enzymes when nivolumab is combined with cabozantinib in RCC In a clinical study of previously u
Eintrag öffnenOpdivo · 4.8 · For patients treated with nivolumab in combination with cabozantinib, data from RCC patients 75 years of age o
Eintrag öffnenOpdivo · 4.8 · For patients treated with nivolumab in combination with cabozantinib, data from RCC patients 75 years of age o
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of diarrhoea, colitis, freq
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of diarrhoea, colitis, freq
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of hypersensitivity/infusio
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of hypersensitivity/infusio
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of liver function test abno
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of liver function test abno
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of nephritis, immune mediat
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of nephritis, immune mediat
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of thyroid disorders was 43
Eintrag öffnen